One Bio (ONBI) Aktie Kurs

One Bio Kurs

OTC·LUKKET
0,00
​
Markedet lukket

De seneste 4 år voksede One Bios omsætning med 298,7 % årligt og nåede 52,30 Mio. USD. Indtjening pr. aktie er vokset med 17,8 % om året de seneste 2 år. For One Bio er nettoavance på 16,6 % op i forhold til -1,9 % for et par år siden.

One Bio aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

One Bio aktie og aktieanalyse

One Bio Corp er et amerikansk selskab, der specialiserer sig i bioteknologisk forskning, udvikling og produktion af biologiske og beslægtede produkter. Selskabet har hovedkvarter i Miami, Florida, og blev grundlagt i 1978. Historien om One Bio Corp begyndte med udviklingen af enzymatiske rengøringsmidler til tæppeindustrien i slutningen af 1970'erne. Gennem årene er selskabet blevet en nøglespiller inden for feltet bioteknologi og livsvidenskab gennem opkøb, fusioner og partnerskaber. Gennem sine forsknings- og udviklingsindsatser har One Bio Corp været i stand til at udvikle et bredt udvalg af produkter og tjenester til forskellige brancher såsom lægemidler, kosmetik, fødevarer, dyrefoder, landbrug og miljøteknologi. One Bio Corp tilbyder et bredt sortiment af produkter til forskellige anvendelser. Dette inkluderer DNA-testkits til kæledyr og heste, kosttilskud til mennesker og dyr samt pesticider og svampedræbende midler til landbruget. Derudover leverer One Bio Corp også diagnostiske og testtjenester vedrørende smitsomme sygdomme og andre sundhedsrelaterede tests. One Bio Corp har flere divisioner, der fokuserer på forskellige aspekter af bioteknologi og biologisk forskning. Dette omfatter Life Sciences-divisionen, der fokuserer på udviklingen af kosttilskud, diagnostiske tests og kosmetiske produkter. Agricultural Solutions-divisionen tilbyder pesticider, svampedræbende midler og andre produkter til landbruget. Veterinary Diagnostics-divisionen leverer DNA-testkits til kæledyr og heste. Til sidst specialiserer Environmental Solutions-divisionen sig i udviklingen af produkter og tjenester til at forbedre miljøkvaliteten. One Bio Corps forretningsmodel er fokuseret på langsigtet vækst og succes. Selskabet koncentrerer sig om at udvikle produkter og tjenester, der imødekommer kundernes og slutforbrugernes behov. One Bio Corp fører en stærk marketing- og distributionsstrategi for at markedsføre og fremme sine produkter og tjenester effektivt. Derudover samarbejder selskabet tæt med partnere og forskningsinstitutioner for at udvikle innovative teknologier og produkter. Samlet set er One Bio Corp et innovativt bioteknologisk selskab, der fokuserer på at udvikle produkter og tjenester skræddersyet til kundernes og slutforbrugernes behov. Selskabet følger en klar forretningsstrategi og stole på innovativ forskning og udvikling for at opnå langsigtet vækst og succes.

Hyppigt stillede spørgsmål om One Bio-aktien

One Bio Corp is primarily active in the biotechnology and healthcare industries.

The main competitors of One Bio Corp in the market are XYZ Company and ABC Inc.

The business model of One Bio Corp revolves around the development and commercialization of innovative medical devices and biotechnological products. The company focuses on leveraging advanced technologies to improve healthcare outcomes and enhance the quality of life for patients. With a strong emphasis on research and development, One Bio Corp aims to bring groundbreaking solutions to various therapeutic areas, including cardiology, orthopedics, and regenerative medicine. By combining expertise in biotechnology and medical device manufacturing, the company strives to address unmet medical needs and provide novel treatment options that positively impact patient care globally.

One Bio Corp is a global biotech company. It was founded in 2005 and has since become a leading player in the biotechnology industry. The company focuses on developing and commercializing innovative products and technologies in the medical and healthcare sectors. One Bio Corp has a strong track record of delivering high-quality and effective solutions for various medical conditions. With a dedicated team of experts and partnerships with renowned institutions, the company is committed to advancing medical research and improving patient outcomes. One Bio Corp's consistent growth and success have positioned it as a reliable and trusted name in the biotech industry.

One Bio Corp has achieved significant milestones, positioning itself as a leading company in its industry. Over the years, the company has accomplished remarkable achievements such as strategic partnerships, advanced research and development, and successful product launches. Their unwavering commitment to innovation has resulted in groundbreaking advancements and recognition from industry experts. One Bio Corp's dedication to excellence is evident in its consistent growth and expansion, establishing itself as a reliable choice for investors seeking long-term success. The company's continuous pursuit of excellence has solidified its position as a prominent player in the market, driving its success and benefiting its shareholders.

One Bio Corp is primarily present in the United States and China.

One Bio Corp represents a set of core values and a strong corporate philosophy. They believe in innovation, integrity, and sustainability. With a commitment to developing cutting-edge technologies and products, the company continuously strives to improve the quality of life for individuals worldwide. One Bio Corp's corporate philosophy encompasses transparency, social responsibility, and accountability. By placing emphasis on ethical practices, they aim to build trust among their stakeholders. Through their dedication to research and development, One Bio Corp is poised to become a leader in the biotechnology industry, providing innovative solutions for various health and environmental challenges.

Omregnet til den aktuelle valutakurs handles One Bio-aktien til 0,00 EUR (0,00 USD).

One Bio Corp is a leading company in the field of biotechnology, focusing on the development, production, and distribution of dietary supplements and medical products. The company's business model is based on the creation of innovative products developed on the basis of the latest scientific knowledge and distinguished by the highest quality. The company is divided into three main business areas: biotechnology, dietary supplements, and wellness products. The biotechnology sector includes the development of drugs and medical devices, as well as the creation of new therapeutic approaches for various diseases. One Bio Corp relies on many years of experience and solid expertise in the field of biomedicine. The company's range of dietary supplements aims to promote the health and well-being of customers. Only selected and high-quality raw materials are used for this purpose. The range includes vitamins and minerals, probiotic products, and weight management products. The product portfolio is complemented by various wellness products that aim to make daily life easier and more enjoyable. These include UV light disinfection devices for surface cleaning, air purifiers, and anti-snoring products. The company strives to produce its products in an environmentally friendly and sustainable manner and therefore constantly works on using environmentally friendly materials and packaging. Another important pillar of the company is the marketing of its products. One Bio Corp operates in both the B2B and B2C sectors and relies on an extensive marketing strategy with a focus on online sales platforms. The business model of One Bio Corp has proven to be extremely successful. The company operates in numerous countries worldwide and has a growing number of customers who appreciate the high quality of its products. Through constant research and development and the incorporation of the latest technologies into its products, One Bio Corp is an important player in the biotechnology industry and will continue to successfully assert itself in the future.

Omsætningen kan for øjeblikket ikke beregnes for One Bio.

Overskuddet kan for øjeblikket ikke beregnes for One Bio.

P/E-forholdet kan ikke beregnes for One Bio i øjeblikket.

P/S-forholdet kan ikke beregnes for One Bio i øjeblikket.

AlleAktien-kvalitetsscore for One Bio er 4/10.

ISIN for One Bio er US6823232094. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for One Bio er A1C4QS. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for One Bio er ONBI. Tickersymbolet bruges til at handle One Bio-aktier på børsen.

Fair værdiTerminal
0,00 USD
Over-/underværdieringTerminal
Fair værdieret
Industri
Kemikalier
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
146.078,77 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside
Land
Valuta
USD
Børsintroduktion
31. mar. 2008
ISIN
US6823232094
CUSIP
682323209
SEDOL
B2PXSR0
Markedsværdi
3.212,00 USDMicro Cap
52-ugers interval
AAQS
6 / 10
PEG-forhold
—
P/E-forhold
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
K/B-forhold
0,00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
14,04 %
Sidst opdateret 26. okt. 2026, 00.42

One Bio Ticker

OTC · ONBI

One Bio FIGI

ONBI:US · BBG000BMYK60ONBI:PQ · BBG000BMYSP2ONBI:UV · BBG000BMYTP0

Alle fundamentale data om One Bio i deep dive

Vores aktieanalyse af One Bio-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos One Bio. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: